Aardvark Therapeutics Inc. Common Stock
AARD | NASDAQ
$5.67
+$0.10 (+1.80%)
Sep 22, 2026, 11:34 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -1.79 | -1.17 | -4.95 | -5.93 | -8 | -5.87 | -15.06 | -22.02 | -26.50 | -49.34 | -75.32 | -145.13 |
PEG Ratio | 0.05 | -0.05 | -0.62 | -0.44 | -0.15 | -0.78 | -0.15 | 1.10 | -0.18 | -10.23 | 23.21 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.68 | 0.95 | 2.69 | 2.36 | 2.14 | 1.08 | -5.68 | -6.63 | -7.23 | n/a | -8.79 | n/a |
P/FCF Ratio | -1.81 | -1.33 | -5.28 | -6.07 | -8.88 | -5.95 | -17.06 | -26.34 | -33.10 | -62 | -111.64 | -193.07 |
P/OCF Ratio | -1.81 | -1.33 | -5.29 | -6.09 | -8.91 | -5.97 | -17.17 | -26.57 | -33.46 | -62.06 | -111.64 | -193.07 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0 | 0 | 0 | 0 | 0 | -0.01 | -0.02 | 0 | n/a | 0 | n/a |
Quick Ratio | 12.63 | 8.06 | 10.61 | 12.03 | 14.04 | 25.86 | 15.05 | 31.65 | 32.67 | n/a | 7.50 | n/a |
Current Ratio | 12.63 | 8.06 | 10.61 | 12.03 | 14.04 | 25.86 | 15.05 | 31.65 | 32.67 | n/a | 7.50 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -19.23% | -24.82% | -16.50% | -13.33% | -10.49% | -6.18% | 16.07% | 9.06% | 12.88% | n/a | 5.86% | n/a |
Return on Assets | -17.66% | -21.90% | -15.02% | -12.25% | -9.74% | -5.93% | -11.33% | -4.99% | -6.25% | n/a | -19.37% | n/a |
Return on Invested Capital | -19.99% | -25.73% | -17.47% | -14.40% | -11.52% | -6.91% | -12.96% | -6.25% | -7.17% | n/a | -24.10% | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AARD